Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15926017rdf:typepubmed:Citationlld:pubmed
pubmed-article:15926017lifeskim:mentionsumls-concept:C0002600lld:lifeskim
pubmed-article:15926017lifeskim:mentionsumls-concept:C0393738lld:lifeskim
pubmed-article:15926017lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15926017lifeskim:mentionsumls-concept:C0699733lld:lifeskim
pubmed-article:15926017lifeskim:mentionsumls-concept:C0243112lld:lifeskim
pubmed-article:15926017lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:15926017lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:15926017pubmed:dateCreated2005-5-31lld:pubmed
pubmed-article:15926017pubmed:abstractTextIn the present study, we examined clinical and laser-evoked potentials (LEP) features in two groups of chronic tension-type headache (CTTH) patients treated with two different approaches: intra-oral appliance of prosthesis, aiming to reduce muscular tenderness, and 10 mg daily amitriptyline. Eighteen patients suffering from CTTH (IHS, 2004) participated in the study. We performed a basal evaluation of clinical features and LEPs in all patients (T0) vs. 12 age- and sex-matched controls; successively, patients were randomly assigned to a two-month treatment by amitriptyline or intra-oral device appliance. The later LEPs, especially the P2 component, were significantly increased in amplitude in the CTTH group. Both the intra-oral prosthesis and amitriptyline significantly reduced headache frequency. Total Tenderness Score was significantly reduced in the group treated by the prosthesis. The amplitude of P2 response elicited by stimulation of pericranial zones showed a reduction after amitriptyline treatment. The results of this study may confirm that pericranial tenderness is primarily a phenomenon initiating a self-perpetuating circuit, favoured by central sensitisation at the level of the cortical nociceptive areas devoted to the attentive and emotive compounds of pain. Both the interventions at the peripheral and central levels may interrupt this reverberating circuit, improving the outcome of headache.lld:pubmed
pubmed-article:15926017pubmed:languageenglld:pubmed
pubmed-article:15926017pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15926017pubmed:citationSubsetIMlld:pubmed
pubmed-article:15926017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15926017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15926017pubmed:statusMEDLINElld:pubmed
pubmed-article:15926017pubmed:monthMaylld:pubmed
pubmed-article:15926017pubmed:issn1590-1874lld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:GencoSSlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:LivreaPPlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:BarileGGlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:MonettiCClld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:LambertiPPlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:GuidoMMlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:de TommasoMMlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:ShevelEElld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:Di VenereDDlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:LibroGGlld:pubmed
pubmed-article:15926017pubmed:authorpubmed-author:SerpinoCClld:pubmed
pubmed-article:15926017pubmed:issnTypePrintlld:pubmed
pubmed-article:15926017pubmed:volume26 Suppl 2lld:pubmed
pubmed-article:15926017pubmed:ownerNLMlld:pubmed
pubmed-article:15926017pubmed:authorsCompleteYlld:pubmed
pubmed-article:15926017pubmed:paginations152-4lld:pubmed
pubmed-article:15926017pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:meshHeadingpubmed-meshheading:15926017...lld:pubmed
pubmed-article:15926017pubmed:year2005lld:pubmed
pubmed-article:15926017pubmed:articleTitleEffects of amitriptyline and intra-oral device appliance on clinical and laser-evoked potentials features in chronic tension-type headache.lld:pubmed
pubmed-article:15926017pubmed:affiliationClinica Neurologica II, Policlinico, Piazza Giulio Cesare 11, I-70124, Bari, Italy. m.detommaso@neurol.uniba,itlld:pubmed
pubmed-article:15926017pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15926017pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15926017pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15926017pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15926017lld:pubmed